phenytoin
This page covers all phenytoin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Nuclear receptor subfamily 1 group I member 3.
Targets
Nuclear receptor subfamily 1 group I member 3
Marketed (1)
- Dilantin · Pfizer · Neuroscience
Phenytoin exerts its therapeutic effect by voltage-dependent blockade of membrane sodium channels.